CAL
GEHC icon

Capital Analysts LLC’s GE HealthCare GEHC Stock Holding History

Capital Analysts LLC’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104K Sell
1,629
-4
-0.2% -$263 ﹤0.01% 835
2026
Q1 		$117K Hold
1,633
– – ﹤0.01% 758
2025
Q4 		$134K Sell
1,633
-19
-1% -$1.48K ﹤0.01% 697
2025
Q3 		$124K Buy
1,652
+280
+20% +$20.9K ﹤0.01% 682
2025
Q2 		$102K Buy
1,372
+271
+25% +$18.9K ﹤0.01% 664
2025
Q1 		$89K Sell
1,101
-83
-7% -$7.13K ﹤0.01% 663
2024
Q4 		$93K Buy
1,184
+3
+0.3% +$255 ﹤0.01% 625
2024
Q3 		$111K Buy
1,181
+60
+5% +$5.04K ﹤0.01% 570
2024
Q2 		$87K Buy
1,121
+13
+1% +$1.06K ﹤0.01% 599
2024
Q1 		$101K Buy
1,108
+651
+142% +$54.2K ﹤0.01% 548
2023
Q4 		$35K Buy
457
+413
+939% +$28.9K ﹤0.01% 723
2023
Q3 		$3K Sell
44
-30
-41% -$2.18K ﹤0.01% 1019
2023
Q2 		$6K Buy
74
+31
+72% +$2.47K ﹤0.01% 870
2023
Q1 		$3K Buy
+43
New +$3.07K ﹤0.01% 900

Other funds holding GEHC

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Capital Analysts LLC's GEHC Position: Q2 2026 in Review

Capital Analysts LLC reduced its GE HealthCare (GEHC) stake by 0.24% in Q2 2026, selling an estimated $263 and leaving 1,629 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #835.

Capital Analysts LLC first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $134K in Q4 2025. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Capital Analysts LLC held 1,629 shares of GE HealthCare worth $104K as of Q2 2026.
  • Capital Analysts LLC sold 4 GE HealthCare shares in Q2 2026, an estimated $263.
  • GE HealthCare made up ﹤0.01% of Capital Analysts LLC's portfolio in Q2 2026, its #835 holding.
  • Capital Analysts LLC first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Capital Analysts LLC's GE HealthCare position peaked at $134K in Q4 2025.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.